Eve Jelstrom

Use of single IRBs for multi-site studies: A case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study

Kim A. Hoffman, P. Korthuis, D. McCarty, 2019, Contemporary clinical trials communications.

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Kim A. Hoffman, D. McCarty, Elizabeth H. Payne, 2022, Addiction.

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)

C. del Rio, L. Metsch, D. Feaster, 2021, Open forum infectious diseases.

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.

W. Ling, G. Woody, K. Carroll, 2016, Addiction.

Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care

K. O’grady, D. Svikis, J. Gryczynski, 2017, Journal of General Internal Medicine.

Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods

Udi E. Ghitza, U. Ghitza, Malia M Oliver, 2022, Substance abuse.

Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods

T. Lovejoy, A. Bunting, J. McCormack, 2023, Addiction Science & Clinical Practice.

PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high.

Lynette Wright, Margaret M. Paschen-Wolff, Eve Jelstrom, 2024, Drug and alcohol dependence.